Malaria Parasites in the Asymptomatic: Looking for the Hay in the Haystack

Trends in Parasitology

Volumn 32, Issue 4, 2016, Pages 296-308

  Galatas, Beatriz ^a,b   Bassat, Quique ^a,b   Mayor, Alfredo ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Manhiça Health Research Center   (Mozambique)

Author keywords

asymptomatic; elimination.; immunity; malaria; tolerance; transmission; virulence

Indexed keywords

ANTIMALARIAL AGENT; ERYTHROCYTE MEMBRANE PROTEIN 1; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ASYMPTOMATIC INFECTION; CELL ADHESION; COMORBIDITY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INNATE IMMUNITY; MALARIA FALCIPARUM; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PREGNANCY; REVIEW; ASYMPTOMATIC DISEASE; DISEASE ERADICATION; IMMUNOLOGY; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; TRANSMISSION;

ASYMPTOMATIC DISEASES; DISEASE ERADICATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84950113740     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.11.015     Document Type: Review

References (105)

1. 1 Casadevall, A., Pirofski, L.A., Host–pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect. Immun. 68 (2000), 6511–6518.
2. 2 Lindblade, K.A., et al. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev. Anti Infect. Ther. 11 (2013), 623–639.
3. 3 Babiker, H.A., et al. The role of asymptomatic P. falciparum parasitaemia in the evolution of antimalarial drug resistance in areas of seasonal transmission. Drug Resist. Updat. 16 (2013), 1–9.
4. 4 Alves, F.P., et al. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J. Med. Entomol. 42 (2005), 777–779.
5. 5 Bousema, T., et al. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat. Rev. Microbiol. 12 (2014), 833–840.
6. 6 Tanner, M., et al. Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med., 13, 2015, 167.
7. 7 WHO. Disease Surveillance for Malaria Elimination. 2012, 6–9 whqlibdoc.who.int/publications/2012/9789241503334_eng.pdf.
8. 8 Gatton, M.L., Cheng, Q., Investigating antigenic variation and other parasite–host interactions in Plasmodium falciparum infections in naive hosts. Parasitology 128 (2004), 367–376.
9. 9 Gatton, M.L., Cheng, Q., Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals. Am. J. Trop. Med. Hyg. 66 (2002), 467–473.
10. 10 Simpson, J.A., et al. Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology 124 (2002), 247–263.
11. 11 Miller, L.H., et al. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19 (2013), 156–167.
12. 12 Oakley, M.S., et al. Clinical and molecular aspects of malaria fever. Trends Parasitol. 27 (2011), 442–449.
13. 13 Smith, T., et al. An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 75 (2006), 56–62.
14. 14 Smith, T., et al. Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. Am. J. Trop. Med. Hyg. 71 (2004), 80–86.
15. 15 Boisier, P., et al. Relationship between parasite density and fever risk in a community exposed to a low level of malaria transmission in Madagascar highlands. Am. J. Trop. Med. Hyg. 67 (2002), 137–140.
16. 16 Chotivanich, K., et al. Parasite multiplication potential and the severity of falciparum malaria. J. Infect. Dis. 181 (2000), 1206–1209.
17. 17 Pinkevych, M., et al. Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population. J. Infect. Dis. 209 (2014), 1136–1143.
18. 18 Mancio-Silva, L., et al. Sir2a regulates rDNA transcription and multiplication rate in the human malaria parasite Plasmodium falciparum. Nat. Commun., 4, 2013, 1530.
19. 19 Duraisingh, M.T., et al. Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum. Cell 121 (2005), 13–24.
20. 20 Merrick, C.J., et al. Epigenetic dysregulation of virulence gene expression in severe Plasmodium falciparum malaria. J. Infect. Dis. 205 (2012), 1593–1600.
21. 21 Mok, S., et al. Drug resistance Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347 (2015), 431–435.
22. 22 Turner, L., et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498 (2013), 502–505.
23. 23 Warimwe, G.M., et al. Plasmodium falciparum var gene expression is modified by host immunity. Proc. Natl. Acad. Sci.U.S.A. 106 (2009), 21801–21806.
24. 24 Smith, J.D., et al. Decoding the language of var genes and Plasmodium falciparum sequestration. Trends Parasitol. 17 (2001), 538–545.
25. 25 Falk, N., et al. Analysis of Plasmodium falciparum var genes expressed in children from Papua New Guinea. J. Infect. Dis. 200 (2009), 347–356.
26. 26 Rottmann, M., et al. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect. Immun. 74 (2006), 3904–3911.
27. 27 Claessens, A., et al. Generation of antigenic diversity in Plasmodium falciparum by structured rearrangement of var genes during mitosis. PLoS Genet., 10, 2014, e1004812.
28. 28 Tukwasibwe, S., et al. Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda. J. Infect. Dis. 210 (2014), 154–157.
29. 29 Ord, R., et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J. Infect. Dis. 196 (2007), 1613–1619.
30. 30 Sonden, K., et al. Asymptomatic multiclonal Plasmodium falciparum infections carried through the dry season predict protection against subsequent clinical Malaria. J. Infect. Dis. 212 (2015), 608–616.
31. 31 Wargo, A.R., et al. Transmission stage investment of malaria parasites in response to in-host competition. Proc. Biol. Sci. 274 (2007), 2629–2638.
32. 32 Medzhitov, R., et al. Disease tolerance as a defense strategy. Science 335 (2012), 936–941.
33. 33 Crompton, P.D., et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 32 (2014), 157–187.
34. 34 Stevenson, M.M., Riley, E.M., Innate immunity to malaria. Nat. Rev. Immunol. 4 (2004), 169–180.
35. 35 Warimwe, G.M., et al. Plasmodium falciparum var gene expression homogeneity as a marker of the host–parasite relationship under different levels of naturally acquired immunity to malaria. PLoS ONE, 8, 2013, e70467.
36. 36 Finney, O.C., et al. Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria. Mol. Cell. Proteomics 13 (2014), 2646–2660.
37. 37 Medeiros, M.M., et al. Natural antibody response to Plasmodium falciparum merozoite antigens MSP5 MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon. BMC Infect. Dis., 13, 2013, 608.
38. 38 Torres, K.J., et al. Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon. J. Infect. Dis. 211 (2015), 1342–1351.
39. 39 Stanisic, D.I., et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 77 (2009), 1165–1174.
40. 40 Duffy, P.E., et al. Variant proteins on the surface of malaria-infected erythrocytes – developing vaccines. Trends Parasitol. 17 (2001), 354–356.
41. 41 Bejon, P., et al. Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect. Immun. 77 (2009), 1917–1923.
42. 42 Laishram, D.D., et al. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar. J., 11, 2012, 29.
43. 43 Guiyedi, V., et al. Asymptomatic Plasmodium falciparum infection in children is associated with increased auto-antibody production, high IL-10 plasma levels and antibodies to merozoite surface protein 3. Malar. J., 14, 2015, 162.
44. 44 Kho, S., et al. Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection. Infect. Immun. 83 (2015), 3224–3232.
45. 45 Wammes, L.J., et al. Asymptomatic plasmodial infection is associated with increased tumor necrosis factor receptor II-expressing regulatory T cells and suppressed type 2 immune responses. J. Infect. Dis. 207 (2013), 1590–1599.
46. 46 Jagannathan, P., et al. IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog., 10, 2014, e1003864.
47. 47 Teirlinck, A.C., et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog., 7, 2011, e1002389.
48. 48 Wipasa, J., et al. Long-lived antibody and B cell memory responses to the human malaria parasites Plasmodium falciparum and Plasmodium vivax. PLoS Pathog., 6, 2010, e1000770.
49. 49 Ndungu, F.M., et al. Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc. Natl. Acad. Sci.U.S.A. 109 (2012), 8247–8252.
50. 50 Miller, M.J., Observations on the natural history of malaria in the semi-resistant West African. Trans. R. Soc. Trop. Med. Hyg. 52 (1958), 152–168.
51. 51 Mackinnon, M.J., et al. Heritability of malaria in Africa. PLoS Med., 2, 2005, e340.
52. 52 Taylor, S.M., Fairhurst, R.M., Malaria parasites and red cell variants: when a house is not a home. Curr. Opin. Hematol. 21 (2014), 193–200.
53. 53 Khan, W.A., et al. Asymptomatic Plasmodium falciparum malaria in pregnant women in the Chittagong Hill Districts of Bangladesh. PLoS ONE, 9, 2014, e98442.
54. 54 Fried, M., Duffy, P.E., Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272 (1996), 1502–1504.
55. 55 Mayor, A., et al. Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar. J., 8, 2009, 9.
56. 56 Serra-Casas, E., et al. Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery. Infect. Immun. 79 (2011), 298–304.
57. 57 Matangila, J.R., et al. Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo. Malar. J., 13, 2014, 132.
58. 58 Boudova, S., et al. Pregnant women are a reservoir of malaria transmission in Blantyre, Malawi. Malar. J., 13, 2014, 506.
59. 59 Andrade, B.B., et al. Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS ONE, 6, 2011, e19841.
60. 60 Salgame, P., et al. Effect of helminth-induced immunity on infections with microbial pathogens. Nat. Immunol. 14 (2013), 1118–1126.
61. 61 Gonzalez, R., et al. HIV and malaria interactions: where do we stand?. Expert Rev. Anti Infect. Ther. 10 (2012), 153–165.
62. 62 Schaible, U.E., Kaufmann, S.H., Malnutrition and infection: complex mechanisms and global impacts. PLoS Med., 4, 2007, e115.
63. 63 O'Meara, W.P., et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 372 (2008), 1555–1562.
64. 64 O'Meara, W.P., et al. Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am. J. Trop. Med. Hyg. 79 (2008), 185–191.
65. 65 Reyburn, H., et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 293 (2005), 1461–1470.
66. 66 Snow, R.W., Marsh, K., The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv. Parasitol. 52 (2002), 235–264.
67. 67 Walton, G.A., On the control of malaria in Freetown, Sierra Leone; control methods and the effects upon the transmission of Plasmodium falciparum resulting from the reduced abundance of Anopheles gambiae. Ann. Trop. Med. Parasitol. 43 (1949), 117–139.
68. 68 Mayor, A., et al. Changing trends in P. falciparum burden, immunity, and disease in pregnancy. N. Engl. J. Med. 373 (2015), 1607–1617.
69. 69 Pull, J.H., Malaria surveillance methods, their uses and limitations. Am. J. Trop. Med. Hyg. 21 (1972), 651–657.
70. 70 Yekutiel, P., Problems of epidemiology in malaria eradication. Bull. World Health Organ. 22 (1960), 669–683.
71. 71 malERA Consultative Group on Monitoring, Evaluation, and Surveillance, A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med., 8, 2011, e1000400.
72. 72 Imwong, M., et al. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand–Myanmar border areas, Cambodia, and Vietnam. Malar. J., 14, 2015, 381.
73. 73 Okell, L.C., et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat. Commun., 3, 2012, 1237.
74. 74 Young, M.D., et al. The infectivity of native malarias in South Carolina to Anopheles quadrimaculatus. Am. J. Trop. Med. Hyg. 28 (1948), 303–311.
75. 75 Bousema, J.T., et al. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar. J., 3, 2004, 18.
76. 76 de Mast, Q., et al. Is asymptomatic malaria really asymptomatic? Hematological, vascular and inflammatory effects of asymptomatic malaria parasitemia. J. Infect. 71 (2015), 587–596.
77. 77 Maketa, V., et al. The relationship between Plasmodium infection, anaemia and nutritional status in asymptomatic children aged under five years living in stable transmission zones in Kinshasa, Democratic Republic of Congo. Malar. J., 14, 2015, 83.
78. 78 Nankabirwa, J., et al. Asymptomatic Plasmodium infection and cognition among primary schoolchildren in a high malaria transmission setting in Uganda. Am. J. Trop. Med. Hyg. 88 (2013), 1102–1108.
79. 79 Boutlis, C.S., et al. Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults. Infect. Immun. 71 (2003), 3682–3689.
80. 80 Koepfli, C., et al. How much remains undetected? Probability of molecular detection of human plasmodia in the field. PLoS ONE, 6, 2011, e19010.
81. 81 Nsobya, S.L., et al. Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children. J. Infect. Dis. 189 (2004), 2220–2226.
82. 82 Baliraine, F.N., et al. High prevalence of asymptomatic Plasmodium falciparum infections in a highland area of western Kenya: a cohort study. J. Infect. Dis. 200 (2009), 66–74.
83. 83 Felger, I., et al. The dynamics of natural Plasmodium falciparum infections. PLoS ONE, 7, 2012, e45542.
84. 84 Szmitko, P.E., et al. Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagn. Microbiol. Infect. Dis. 63 (2009), 105–107.
85. 85 Sama, W., et al. Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am. J. Trop. Med. Hyg. 70 (2004), 625–634.
86. 86 Bretscher, M.T., et al. The distribution of Plasmodium falciparum infection durations. Epidemics 3 (2011), 109–118.
87. 87 Ghani, A.C., et al. Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends. PLoS ONE, 4, 2009, e4383.
88. 88 Hoyer, S., et al. Focused screening and treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia. PLoS ONE, 7, 2012, e45797.
89. 89 Mosha, J.F., et al. Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar. J., 12, 2013, 221.
90. 90 Clarke, S.E., et al. Risk of malaria attacks in Gambian children is greater away from malaria vector breeding sites. Trans. R. Soc. Trop. Med. Hyg. 96 (2002), 499–506.
91. 91 de Roode, J.C., et al. Virulence and competitive ability in genetically diverse malaria infections. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 7624–7628.
92. 92 Riley, E.M., et al. Regulating immunity to malaria. Parasite Immunol. 28 (2006), 35–49.
93. 93 Schofield, L., et al. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418 (2002), 785–789.
94. 94 Bate, C.A., et al. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology 76 (1992), 35–41.
95. 95 Boutlis, C.S., et al. Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr. Top. Microbiol. Immunol. 297 (2005), 145–185.
96. 96 Anstey, N.M., et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184 (1996), 557–567.
97. 97 Jeney, V., et al. Control of disease tolerance to malaria by nitric oxide and carbon monoxide. Cell Rep. 8 (2014), 126–136.
98. 98 Boutlis, C.S., et al. Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia. Infect. Immun. 72 (2004), 6932–6938.
99. + γδ T cells are associated with clinical tolerance to malaria. Sci. Transl. Med., 6, 2014, 251ra117.
100. 100 Portugal, S., et al. Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog., 10, 2014, e1004079.
101. 101 Ferreira, A., et al. A central role for free heme in the pathogenesis of severe malaria: the missing link?. J. Mol. Med. (Berl.) 86 (2008), 1097–1111.
102. 102 Seixas, E., et al. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci.U.S.A. 106 (2009), 15837–15842.
103. 103 Ganz, T., Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 21 (2009), 63–67.
104. 104 Das, L.K., Malaria during pregnancy and its effects on foetus in a tribal area of Koraput District, Orissa. Indian J. Malariol. 37 (2000), 11–17.
105. 105 Gozzelino, R., et al. Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 12 (2012), 693–704.